Originated by VidaPeps LLC, which attests it authorized this test as the brand of record.
Axiom confirmed this brand is a registered Axiom account. This does not confirm the product's origin, chain of custody, or that the brand authorized this specific test.
- L1Identity
- L2Purity
- L3Net Peptide Content
- L4Sterility
- L5Endotoxin
- L6Heavy Metals
- L7Stability
- L8Fentanyl Screen
Test Results
Select a test for its full result| Test | Reference standard | Result | Verdict |
|---|---|---|---|
| Referenceevery vial within ±1 Da of 4731.421 Da | Resultmean 4731.421 Da over 4 vials | PASS | |
| ReferenceQualified purity criterion required · Lot uniformity CV ≤ 1% · Source Axiom Analytics lot-uniformity criterion for purity (internal, not compendial) | Resultmean 99.77% over 4 vials (99.67–99.89%), CV 0.09% | PASS | |
| Referencewithin ±10% of 60 mg and CV at or below 5% | Resultmean 60.22 mg over 4 vials, CV 0.12% | PASS | |
| ReferenceRapid PCR screen | ResultTarget DNA not detected | PASS | |
| Reference≤ 0.5 EU/mg (USP <85>) | Result0.05 EU/mg | PASS | |
| ReferenceUSP <232>/<233> limits | ResultAll below limits | PASS | |
| ReferencepH within 5.50 - 7.50 and degradation below 5% | ResultpH 5.79, 2% degradation at 24 h | PASS | |
| Referenceno fentanyl or analog at or above 1 ng/mg | Resultnone detected | PASS |
REPORTING SCOPE & LIMITATIONS
- [Purity]The chromatographic trace was not retained for this certificate. The purity value and its acceptance limit are unaffected.
- [Identity]The mass spectrum was not retained for this certificate. Identity is reported from the recorded accurate mass against its theoretical value.
- [Sterility · Rapid PCR]DNA-target research screen only. It detects microbial DNA from viable and non-viable organisms alike, and is neither viable-CFU enumeration under USP <61> nor a batch sterility determination under USP <71>.
- [Fentanyl Screen]Targeted LC-MS/MS adulterant screen, reported as detected or not detected against its stated detection limit. A harm-reduction research screen, not an exhaustive adulterant panel.
Results relate only to the item or portion tested. Unless sampling was performed or witnessed by Axiom Analytics, the laboratory does not attest that the submitted sample represents the wider lot or batch. A PASS designation means only that the reported result met the specification shown. It does not establish safety, efficacy, regulatory approval, legality, or suitability for human or animal use.
All analytical testing, validation reports, and interactive Certificates of Analysis (COAs) provided by Axiom Analytics are intended strictly for Research Use Only (RUO) in in-vitro or laboratory animal model environments. Axiom Analytics does not analyze, validate, evaluate, or make any representations regarding the safety, efficacy, toxicity, or legality of any tested substance for human or animal consumption, veterinary use, clinical diagnostics, food additives, cosmetics, or household applications.
Physical instrument analysis is performed at Axiom Analytics' discretion (based on method, capacity, and order volume), either in Axiom's own laboratory under its documented quality system or by an independent partner laboratory engaged under confidentiality. Where analysis is subcontracted, the method is performed within the partner laboratory's published ISO/IEC 17025 scope of accreditation for that method, not merely at a laboratory holding ISO/IEC 17025 accreditation. Axiom Analytics does not itself currently hold ISO/IEC 17025 accreditation. The method-validation status of each reported result is identified beside that result. Partner laboratory identities are not disclosed: samples are analyzed under double-blind conditions, identified only by an internal lot ID.
To the maximum extent permitted by applicable law, the cumulative liability of Axiom Analytics, its officers, employees, and third-party laboratory partners to the client or any third party for any claims, losses, damages, or liabilities of any kind (including but not limited to direct, indirect, special, incidental, punitive, or consequential damages) shall be strictly limited to, and shall not exceed, the exact dollar amount paid by the client to Axiom Analytics for the specific individual analytical test run from which the liability arose.